Sangamo Therapeutics Inc. buy Truist Financial Co.
Start price
23.01.25
/
50%
€1.12
Target price
23.01.26
€4.80
Performance (%)
-65.71%
Price
09.01.26
€0.38
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Sangamo Therapeutics Inc. is performing very badly with a performance of -65.71%. This prediction currently runs until 23.01.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sangamo Therapeutics Inc. | 3.593% | 3.593% |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Truist Financial Co. from $7.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for SGMO provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.04
13.12.24
13.12.24
€6.66
13.12.25
13.12.25
-81.30%
14.12.25
14.12.25
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.93
15.08.23
15.08.23
€6.40
15.08.24
15.08.24
-13.17%
16.08.24
16.08.24